SpaceX Dragon experiments on artificial retinas and… · SpaceX Daily 🚀
| View this email in your browser |
![]() SpaceX DailyFollow SpaceX as a public company — launches, Starlink, Starship, and the SPCX market picture, every day.
|
By the numbers
|
🎧 Today's episode Episode 133 · SpaceX Dragon experiments on artificial retinas and brain tissue now run in sustained microgravity aboard the station. 2026-10-17 ▶ Listen now |
| Heads up: Educational and entertainment only. Not financial advice. Any trades discussed are simulated. Always do your own research. |
Top News
The CounterpointVodafone has taken formal concerns about SpaceX spectrum use to regulators in Brussels while several Wall Street firms maintain positive ratings on the company. The move highlights ongoing European pushback on Starlink licensing and interference claims. Resolution would require coordination between national regulators and the European Commission. European operators continue to press for technical studies on signal overlap before additional approvals advance. Source: ad-hoc-news.de AI & ComputeEngineering Deep DiveMicrogravity removes the constant sedimentation and buoyancy-driven flows that dominate fluid behavior on Earth. In the Dragon experiments, this absence lets cells organize into three-dimensional structures that more closely match native tissue architecture. Retinal cells, for example, can form layered sheets without gravitational settling that would otherwise distort the geometry needed for light-sensitive function. Brain organoids similarly develop without the mechanical stress gradients that flatten or shear delicate neural networks in terrestrial bioreactors. The same environment allows glass precursors to nucleate and grow without density-driven convection currents that normally seed defects. Heart tissue models benefit because cardiomyocytes can align and couple electrically across larger volumes when freed from gravitational compression. These outcomes depend on the Dragon's ability to deliver and maintain stable thermal and power conditions for weeks inside the station's microgravity laboratory. The data returned will quantify how much the removal of one force changes the yield and quality of each manufactured structure. The final IROSA solar arrays will supply additional power margins that support longer-duration runs of these sensitive payloads. The absence of buoyancy convection also changes how nutrients and waste products move through culture media. On Earth, density differences create natural mixing that can be uneven; in orbit the only transport is diffusion or forced flow from pumps. Researchers therefore design perfusion systems that must compensate for the missing convective term. Artificial retina production exploits this change because photoreceptor precursors can settle into precise radial layers without the settling velocity that compresses stacks on the ground. Glass formation studies similarly track nucleation rates when gravitational buoyancy no longer sweeps away early crystals. The heart tissue models gain from the same condition because electrical coupling between cells proceeds without the compressive load that alters gap-junction formation in 1-g bioreactors. Each experiment therefore isolates a single variable—gravitational acceleration—to measure its contribution to final structure quality. The 6,300-pound cargo mass delivered on this flight includes both the biological payloads and the infrastructure that keeps them alive. Power margins from the arriving IROSA arrays will keep incubators and perfusion pumps running without competing with station systems. Thermal control inside the Dragon trunk and the station's EXPRESS racks must hold setpoints within narrow bands so that cell viability does not drop during the weeks of microgravity exposure. These engineering constraints illustrate why sustained access to orbital laboratories remains the limiting factor for scaling tissue-manufacturing yields. Data from the current set of experiments will feed directly into the design of the next-generation culture hardware that future Dragon flights will carry. Market WatchSPCX is at $146.03, -1.5% vs the previous close. SpaceX will post its first earnings as a public company on October 20. Source: ir.spacex.com The hardware that turns microgravity into measurable tissue yields is already on orbit. |
💬 Reply to this email — Patrick reads every one. Share: X · LinkedIn · WhatsApp Forwarded this email? Subscribe here — it's free. |
📺 Watch on YouTube · 📝 Read the blog · 🖼 Free image gallery (CC BY-SA) · 📊 Data Hub & Story Trackers · 🧭 Start Here Nerra Network · AI-narrated voice (Grok TTS) · Editorial by Patrick You're receiving this because you subscribed to SpaceX Daily on nerranetwork.com. |
| Issue #133 · SpaceX Daily · Oct 17, 2026 |
